Related Experiment Video
Updated: May 14, 2026

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
Published on: November 6, 2018
Stability of dilute oral morphine solution for neonatal abstinence syndrome
Jason Sauberan1, Steven Rossi, Jae H Kim
1University of California, San Diego (UCSD) Medical Center, Department of Pharmacy and UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USA. jsauberan@ucsd.edu
Background:
Oral morphine is a recommended option for the treatment of neonatal abstinence syndrome (NAS). Commercially available oral morphine solution products in the United States are not formulated in concentrations appropriate for use in neonates.
Objective:
To test the stability of a diluted oral morphine solution for treatment of NAS.
Methods:
Ethanol-free morphine 2 mg/mL oral solution was diluted to 0.4 mg/mL with sterile water and stored in a light protected container at room temperature (20°C-25°C). The change in morphine concentration over time was measured by liquid chromatography mass spectrometry with simultaneous ultraviolet diode array detection.
Results:
: The test morphine solution retained 107% of its original concentration after 60 days.
Conclusion:
Extemporaneously prepared 0.4 mg/mL oral morphine solution is suitable for use in the treatment of NAS as a potentially safer alternative to opium-containing agents.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
IV Infusion to Oral Dosing: Conversion Methods
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

